Evidence map›Paper›PMID 39060417›Full record

ArticleNature2024

Publisher Correction: Interferon subverts an AHR-JUN axis to promote CXCL13

Calvin Law, Vanessa Sue Wacleche, Ye Cao, Arundhati Pillai, John Sowerby, Brandon Hancock, Alice Horisberger, Sabrina Bracero, Viktoriya Skidanova, Zhihan Li and 26 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

36 authors.

Calvin Law *Department of Biochemistry and Molecular Genetics, The Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.ORCID http://orcid.org/0000-0002-6784-0085
Vanessa Sue Wacleche *Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Ye Cao *Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Arundhati PillaiDepartment of Biochemistry and Molecular Genetics, The Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.ORCID http://orcid.org/0000-0002-7234-8255
John SowerbyDivision of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Brandon HancockDepartment of Biochemistry and Molecular Genetics, The Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Alice HorisbergerDivision of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.ORCID http://orcid.org/0000-0002-3732-8662
Sabrina BraceroDivision of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Viktoriya SkidanovaDivision of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Zhihan LiDivision of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Ifeoluwakiisi AdejoorinDivision of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.ORCID http://orcid.org/0000-0001-8967-5896
Eilish DillonDivision of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.ORCID http://orcid.org/0009-0007-6070-5976
Isaac J BenqueDivision of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Diana Pena NunezDivision of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Daimon P SimmonsDivision of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Joshua KeeganDepartment of Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Lin ChenDivision of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.ORCID http://orcid.org/0000-0001-5072-4152
Tina BakerAstraZeneca, Gaithersburg, MD, USA.
Phillip Z BrohawnAstraZeneca, Gaithersburg, MD, USA.
Hussein Al-MossawiAstraZeneca, Late Respiratory and Immunology, Cambridge, UK.
Ling-Yang HaoDiscovery Immunology, Janssen Research & Development, Spring House, PA, USA.
Brian JonesDiscovery Immunology, Janssen Research & Development, Spring House, PA, USA.
Navin RaoDiscovery Immunology, Janssen Research & Development, Spring House, PA, USA.
Yujie QuMerck & Co., Inc., Rahway, NJ, USA.
Stephen E AlvesMerck & Co., Inc., Rahway, NJ, USA.
Accelerating Medicines Partnership: RA/SLE Network
A Helena JonssonDivision of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.ORCID http://orcid.org/0000-0002-9558-2474
Katharina S ShawDepartment of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Ruth Ann VleugelsDepartment of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Elena MassarottiDivision of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Karen H CostenbaderDivision of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Michael B BrennerDivision of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.ORCID http://orcid.org/0000-0001-6202-8445
James A LedererDepartment of Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.ORCID http://orcid.org/0000-0002-6445-252X
Judd F HultquistDivision of Infectious Diseases, The Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.ORCID http://orcid.org/0000-0001-6424-4280
Jaehyuk ChoiDepartment of Biochemistry and Molecular Genetics, The Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. jaehyuk.choi@northwestern.edu.ORCID http://orcid.org/0000-0003-2379-2226
Deepak A RaoDivision of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. darao@bwh.harvard.edu.ORCID http://orcid.org/0000-0001-9672-7746

Funding

Elucidating transcriptional and epigenetic regulators of aggressive cutaneous T cell lymphomaF31CA268839 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI LAW, CALVIN YUEN YEE · 2022 to 2023
$85k
NCI NIH HHS F31 CA268839
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.